
NeosRx CEO Jeff Dunn, Pharm.D., MBA, explains how 340B claims can disadvantage PBMs because of loss of rebates..

NeosRx CEO Jeff Dunn, Pharm.D., MBA, explains how 340B claims can disadvantage PBMs because of loss of rebates..

Patients facing higher out-of-pocket costs predicted procedures would hurt more than procedures with no copay, according to the results of a recent Carnegie Mellon study.

Drug launch prices are rising, but Benjamin N. Rome, M.D., M.P.H., and colleagues found no evidence manufacturers raised them in response to the Inflation Reduction Act.

DPP-1 inhibitors are oral small molecules that block the enzyme responsible for activating neutrophil elastase, and in the pivotal ASPEN trial, brensocatib reduced annualized exacerbations by about 20% versus placebo.

DPP-1 inhibitors are oral small molecules that block the enzyme responsible for activating neutrophil elastase, and in the pivotal ASPEN trial, brensocatib reduced annualized exacerbations by about 20% versus placebo.

Naik says a strong recommendation for infliximab and a call for routine pain assessment are the HS guideline changes most likely to change clinical practice.

New guidelines for care of hidradenitis suppurativa advise against radiotherapy for children and adolescents, citing its long-term risks and safer treatment options.

Hidradenitis suppurativa was long thought to be a rare condition, but global data put the prevalence at 1%, says Naik, co-chair of the new AAD-HS Foundation guidelines for the disease.

Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.

Only 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.

Model N's Jesse Mendelsohn explains why drug manufacturers argued that a 340B rebates instead of upfront discounts will avoid an overlapping maximum fair price and 340B discounts

The PHOTON trial showed that higher-dose therapy maintained visual and anatomic gains with markedly fewer injections. The panel reviews trial design, durability outcomes, and the cost analysis built on those data.

Longer treatment intervals can renew patient engagement and improve adherence. Dr. Patel explains how he weighs safety, efficacy, and early anatomic response when selecting an anti-VEGF agent for DME.

People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.

Fifteen years after HCCI's first report on healthcare cost, CEO Katie Martin says prices, not utilization, are still pushing healthcare costs higher in the employer-insured market.

Topical therapies can be used as maintenance to prevent new lesions, such as long-term low-dose topical clindamycin, Porter said, and topical JAK inhibitors such as ruxolitinib [sold under the brand name Opzelura] are being studied.

Telling patients that being overweight or smoking caused their HS puts the responsibility back on them and has created barriers to seeking and staying in care, Porter said.

Geisinger Health Plan President Jeremy Gaskill says the possibility that a growing number of patients won't have health insurance could put tremendous financial pressure on the plan's providers.

Christopher Stanley, M.D., MBA, says Henry Ford Health now projects its 2027 employee healthcare insurance premiums to increase half as much as what had been expected, partly because of Populance’s to bring about cost-effective care.

Each exacerbation increases a patient's risk of future flares, creating a self-reinforcing cycle that underscores the value of consistent self-management between office visits.

Clinicians have only four limited categories of tools for non-cystic fibrosis bronchiectasis, with little evidence for preventing exacerbations, and the resulting hospitalizations can be lengthy, resource-intensive, and recurrent.

Annesha White, Pharm.D., M.S., Ph.D., and Fredrick Manasseh, Pharm.D., MBA, BCGP, explain where AI helps managed care pharmacy, where bias creeps in and what skills pharmacists need to oversee it.

Unifying care management doubled patient outreach with the same staff, and virtual physical therapy is cutting costs, says Populance's Christopher Stanley, M.D.

Christopher Stanley, M.D., MBA, says Henry Ford Health's growth has led Populance to put its push for outside customers on hold and focus on its own system.

Rising drug prices, limited plan coverage, prior authorization demands, and denials all constrain DME care. Dr. Patel describes how retina practices work to secure the most effective therapy for patients.

Patients with DME often return with advanced disease after missing visits. The panel examines how frequent injections, work obligations, and competing health needs create a cycle of lost follow-up and poorer visual outcomes.

Geisinger Health Plan President Jeremy Gaskill says being owned by a health system aligns incentives, cuts payer-provider busywork and speeds care to patients.

Geisinger Health Plan expects Medicaid enrollment to fall roughly 10% as H.R. 1 takes effect, President Jeremy Gaskill says, though the timing is still unclear.

As other insurers pull back, Geisinger Health Plan isn’t exiting any Medicare Advantage plans for 2027 and expects to grow, President Jeremy Gaskill says.

Hidradenitis suppurativa diagnosis is a clinical diagnosis based on typical lesions in typical locations, such as the axilla, groin and buttocks, along with a pattern of chronicity, Porter said.